Search results

One year after the release of the UN Secretary-General’s High-Level Panel on Access to Medicines landmark report, this paper assesses the level of implementation by countries and institutions and recommends ways to use the report to improve both innovation and access to medicines.

This global tax platform represents a step in a long road towards building a fairer and more transparent global tax system. The platform must be able to deliver tangible results and combat inequality, but most importantly, it must give the poorest countries a voice.

An explosion in extreme wealth and income is exacerbating inequality and hindering the world’s ability to tackle poverty, Oxfam warned today in a briefing published ahead of the World Economic Forum in Davos next week.

The Credit Suisse Global Wealth Report shows once again that economic inequality remains at shockingly high levels.  The richest 1 percent now has as much wealth as the rest of the world combined.

Energy security, climate change and the global economy were among the main topics the G7 leaders addressed during the

The International Monetary Fund (IMF) today publishes a major new report on global corporate taxation: “Spillov

The COVID-19 crisis cost women around the world at least $800 billion in lost income in 2020, equivalent to more than the combined GDP of 98 countries, said Oxfam today.  

Global dividend payments to shareholders grew on average 14 times faster than worker pay in 31 countries, which together account for 81 percent of global GDP, between 2020 and 2023, reveals Oxfam’s new analysis ahead of International Workers’ Day (May 1). 

Rich countries must open the way to cheaper mass-produced COVID-19 vaccines in order to protect every person in the world and avert a $9 trillion “worst case” global economic catastrophe, said Oxfam today. They should also agree this week to inject $650 billion more into the global economy to help developing countries cope with the pandemic’s already devasting effects.

The supply of safe and effective vaccines for all is being artificially rationed because of the protection of exclusive rights and monopolies of pharmaceutical corporations, the People’s Vaccine Alliance said today.